Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Fernando M. Coelho, Sr., MD, PhD | No disclosure on file |
| Peter Tai, MD (Toronto Western Hospital) | No disclosure on file |
| Nathalie Jette, MD, MSc, FRCPC, FÂ鶹´«Ã½Ó³» (University of Calgary) | Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES. |
| Danielle M. Andrade, MD (University of Toronto) | The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to Â鶹´«Ã½Ó³» interests or activities. |